Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Accolade Inc (NQ: ACCD )

9.060 +0.330 (+3.78%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 480,666
Open 8.710
Bid (Size) 9.060 (18)
Ask (Size) 9.070 (34)
Prev. Close 8.730
Today's Range 8.580 - 9.105
52wk Range 6.330 - 17.00
Shares Outstanding 76,232,192
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Expert Ratings for Accolade
Via Benzinga
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azenta, Inc. (NASDAQ: AZTA) rose on Tuesday after the company reported better-than-expected fourth-quarter... 
Via Benzinga
Topics Stocks
Exposures US Equities

Performance

YTD
+23.77%
+23.77%
1 Month
+39.38%
+39.38%
3 Month
-32.84%
-32.84%
6 Month
-34.40%
-34.40%
1 Year
+2.60%
+2.60%

More News

Read More
1 Market-Beating Stock to Buy Near Its 52-Week High
Via The Motley Fool
Alignment Healthcare's Valuation Shows Promise In A Competitive Market: Analyst
Via Benzinga
Why Shares of Accolade Fell This Week
Via The Motley Fool
Earnings Outlook For Accolade
Via Benzinga
The Latest Analyst Ratings for Accolade
Via Benzinga
Obesity Medication Insurance Coverage? Employers Embrace the Inclusion of Novo Nordisk's Wegovy in Health Coverage
Via Benzinga
Why Eli Lilly Stock Crawled Higher Today
Via The Motley Fool
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Raymond James Maintains Outperform Rating for Accolade: Here's What You Need To Know
Via Benzinga
Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
Via Benzinga
MaxCyte, Rivian Automotive And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Conagra Brands, Constellation Brands And 3 Stocks To Watch Heading Into Thursday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Why Accolade Stock Is Falling After-Hours
Via Benzinga
Accolade Announces Results for Fiscal Second Quarter 2024
From Accolade, Inc.
Via GlobeNewswire
Accolade Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Via Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Cathie Wood Just Sold Nvidia -- and Bought These 5 Potentially Explosive Growth Stocks Again
Via The Motley Fool
Cathie Wood's Bullish Stance on Flying Cars: Ark Buys $3.9M Worth of Archer Aviation Shares
Via Benzinga
Cathie Wood's Ark Invest Adjusts Portfolio — Sells Nvidia Shares Worth Nearly $1.9M Amid AI Surge
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks
Via The Motley Fool
Every AI Stock Cathie Wood Owns, Ranked From Best to Worst
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.